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Background: Holothuria arenicola is the most important and abundant sea cucumber species in the Mediterranean
Sea on the Egyptian coast. The present study aims to assess the anti-oxidative and anticholestatic effects of the sea
cucumber Holothuria arenicola extract (HaE) in a model of bile duct ligation in male albino rats.
Methods: Fifty four male Wistar albino rats were assigned into two main groups, the Sham-operated control and
bile duct ligated (BDL) group. After 14 days of surgery, the animals of the group I (Sham control) received distilled
water only for 7, 14 and 28 days. Second group (BDL group) was divided into 2 subgroups, animals of these subgroups
treated for 7, 14 and 28 consecutive days as follow: subgroup I (BDL), rats of this subgroup administered distilled water
orally. Subgroup II (HaE), animals of this subgroup treated orally with HaE (200 mg/kg body weight).
Results: The HaE revealed significant antifibrotic effect as evident by decreasing the levels of total conjugated and
unconjugated bilirubin and the activities of serum aminotransferases (ASAT and ALAT) and alkaline phosphatase
(ALP) as well as malondialdehyde (MDA) level, and increasing the serum albumin, glutathione reduced (GSH)
levels. Treatment with HaE normalized the antioxidant enzyme, glutathione-S-transferase (GST), superoxide dismutase
(SOD) and catalase (CAT) activities activities.
Conclusion: The present prospective study correlated the antifibrotic effect of HaE to its direct antioxidant effect that
can be related to its contents of phenolic compounds specially chlorogenic acid, pyrogallol, rutin and coumaric acid.
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Cholestasis represents the consequence of impaired bile
formation and generally classified as extra- and intrahe-
patic [1]. Cholestasis is a reduction in bile flow that leads
to the intrahepatic accumulation of bile acids and other
toxic compounds with progression of liver pathology,
including hepatocellular injury and fibrosis [2]. The failure
of bile salts excretion in cholestasis leads to retention of
hydrophobic bile salts within the hepatocytes causing
apoptosis and necrosis [3]. Moreover, abnormal flux of
bile acids and bilirubin in the liver leads to retention and
accumulation of toxic hydrophobic bile salts within hepa-
tocytes [4], causing inflammatory reactions, hepatocyte
death, and periductular fibrosis [5]. Recent studies have
demonstrated that inflammatory injuries and oxidative
stress occur in the liver with cholestasis [6,7].Correspondence: Sohairfahmy@gmail.com
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unless otherwise stated.Oxidative stress has been implicated in the process of
fibrogenesis [8,9]. Cholestatic liver fibrosis, characterized
by excessive accumulation of extracellular matrix (ECM)
proteins, is associated with bile acid-induced oxidative
stress and lipid peroxidation [10]. Furthermore, oxidative
stress aggravates liver fibrosis via stellate cell activation
[11]. Bile duct ligation (BDL) is a typical model of biliary
cholestasis in animals [12], that induced oxidative dam-
age and fibrosis in rats [13]. Moreover, the bile salts are
partly responsible for the plasma membrane damage
seen in the bile-duct ligated models that leads to further
oxidative stress [14,15].
The problems associated with antifibrotic drugs are
chronic administration, the reduced therapeutic effects
and toxicity, so developing antifibrotics from natural
products may reduce the risk of toxicity and maintain
the therapeutic effectiveness when they used clinically
[16]. As a consequence of an increasing demand for the
therapeutic drugs, products from marine sources haveis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and as a source material for the development of drugs
[17]. Sea cucumber Holothuria is a gelatinous marine
resource that is shaped as a cucumber. It is considered
“sea ginseng” because of its known medicinal properties
aside from its nutritional value. The therapeutic use of
sea cucumbers for healing is established, where they
used for joint pain, tendonitis and sprains [18]. Another
report has demonstrated the antinociceptive property
of gamat (Holothuria spp) [19]. Sea cucumber is also
remarkably rich in vitamins, trace elements, and polysac-
charides (condroitin sulfate), that reduce arthritis pain
and inhibit viral activities, and saponin glycosides that
inhibit cancer activities [20]. Recently, Esmat et al. [21]
revealed that the sea cucumber mixed extract contains
physiologically active phenolic compounds with anti-
oxidant activity that afforded a potential hepatoprotec-
tive activity against thioacetamide induced liver injury
in a rat model.
Holothuria arenicola is the most important and abun-
dant sea cucumber species in the Mediterranean Sea on
the Egyptian coast [22]. The present study aims to assess
the anticholestatic effects of the sea cucumber Holothuria
arenicola extract (HaE) in a model of bile duct ligation




Sea cucumbers (Holothuria arenicola) were collected
from the Abu – Qir Bay in the Egyptian Mediterranean
coast of the eastern Alexandrian coast (May-June 2012).
The animals were transported to our laboratory in an ice
box containing ice cubes and a few pinches of table salt.
The animals were immediately washed under running
tap water and cut open, and all visceral organs were
removed and then the body walls of the animals were
stored at _20°C until processing.
Preparation of the Holothuria arenicola extract
The phosphate buffer extract was prepared according to
the method of Yasumoto et al. [23]. The body wall of
the animals was cut into small parts and blended in
phosphate buffer (in a volume = 4 ml X tissue weight)
and extracted at room- temperature (25°C) with pH 7.2
for 5 hours. The filtered was collected immediately, con-
centrated and lyophilized using lyophilizer (LABCONCO
lyophilizer, shell freeze system, USA).
Antioxidant activity
Free radical scavenging activity
The free radical scavenging activities of the extract and
ascorbic acid were analyzed by the DPPH assay [24]. A
1.0 ml of the test extract, at gradient final concentrationsof 10 - 80 mg/ml, was mixed with 2 ml of 0.3 mM
DPPH solution in MeOH in a cuvette. The absorbance
was taken at 517 nm after 20 minutes of incubation in
the dark at room temperature. The experiment was done
in triplicates. The percentage antioxidant activity was
calculated as follows:
%Antioxidant Activity [AA] = 100 - [{(Abssample –
Absblank) X 100}/Abscontrol]. Where Abssample was the
absorbance of sample solution (2.0 ml) + DPPH solution
(1.0 ml, 0.3 mM), Absblank was the absorbance of
Methanol (1.0 ml) + sample solution (2.0 ml), Abscontrol
was the absorbance of DPPH solution (1.0 ml, 0.3 mM) +
methanol (2.0 ml).
High-performance liquid chromatography analysis
The phenolic components of sea cucumber extract were
separated by high performance liquid chromatography using
an Agilent 1100 device (Waldborn, Germany) equipped with
a Zorbax reversed-phase 300SB C18 column (250–4.6 mm)
with 5-mm particle size (Lawrence, KS, USA) and ultraviolet
detector (G1314A) adjusted at 280 NM. Sample and
authentic standards (50 mL; chlorogenic acid, coumaric
acid, catechin, ascorbic acid, pyrogallol, and rutin) dis-
solved in dimethyl sulfoxide and acidified with a drop of
acetic acid; then they injected onto the column. The mobile
phase was 0.4% formic acid and acetonitrile (60:40, v/v)
with a constant flow rate of 1 ml/min. The isolated
peaks of the phenolic compounds in the sample were
identified by comparing their relative retention times
with those of the standards, and then the concentration
(percentage) of each compound was calculated as peak
area integration.
Ethical consideration
Experimental protocols and procedures used in this
study were approved by the Cairo University, Faculty of
Science Institutional Animal Care and Use Committee
(IACUC) (Egypt), (CUFS/F/06/13). All the experimental
procedures were carried out in accordance with inter-
national guidelines for the care and use of laboratory
animals.
Experimental animals
The experimental animals used in this study were male
Wistar rats (Rattus norvegicus) weighing 150–160 ± 5 g.
The animals were obtained from the National Research
Center (NRC, Dokki, Giza). Animals were grouped and
housed in polyacrylic cages (six animals per cage) in the
well– ventilated animal house of the Department of
Zoology, Faculty of Science, Cairo University. Animals
were given food and water ad libitum. Rats were main-
tained in a friendly environment with a 12 h/12 h light–
dark cycle at room temperature (22°C–25°C). Rats were
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commencement of the experiment.
Component of diet
The diet containing (~22% protein, ~3.5% fats, ~ 0.25%
vitamins, ~ 0.5% sodium chloride, ~ 0.72% molasses, ~ 60%
maize, ~ 20% soybeans, ~ 10% concentrate fattening,
and ~ 5% bran).
Toxicity study (OECD 420)
Wistar rats weighing (150–160 g) were used for acute tox-
icity study. The animals (12 rats) were divided into control
and test groups containing six animals each. The rats were
administered orally with sea cucumbers Holothuria areni-
cola extract (HaE) at dose levels of 5 g/kg (high dosage)
and 2 g/kg (low dosage). Normal control rats received the
same amount of vehicle (distilled water) only. Animals
were observed carefully for 24 hours after extract adminis-
tration and then for the next 14 days. At the end of this
experimental period, the rats were observed for signs of
toxicity, morphological behavior, and mortality. Acute tox-
icity was evaluated based on the number of deaths (if any).
Acute toxicity was calculated as OECD guidelines 420
(Fixed dose method) [25,26].
Bile duct ligation induced liver damage
Bile duct ligation performed according to Vogel and
Vogel [27]. Rats were anesthetized with ketamine and
chlorpromazine (100 mg/kg ketamine and 0.75 mg/kg
chlorpromazine; ip). Laparotomy was performed under
antiseptic conditions. A mid-line incision in the abdo-
men was made, exposing the muscle layers and the linea
alba, that was then incised over a length corresponding
to the skin incision. The edge of the liver was then
raised and the duodenum pulled down to expose the
common bile duct, which pursues an almost straight
course of about 3 cm from the hilum of the liver to its
opening into the duodenum. There is no gall bladder,
and the duct was embedded for the greater part of its
length in the pancreas, which opens into it by numerous
small ducts. A blunt aneurysm needle was passed under
the part of the duct selected, stripping the pancreas away
with care, and the duct was divided between double liga-
tures of cotton thread. The peritoneum and the muscle
layers as well as the skin wound were closed with cotton
stitches. In sham-operated rats, abdominal incision was
made without a bile duct ligation.
Experimental design
Fifty four male Wistar rats were assigned into two main
groups, the Sham-operated control (18 rats/group) and
bile duct ligated (BDL) group (36 rats/group). The bile
ducts of animals of group II were ligated. After 14 days
of surgery, the animals of group I received distilled wateronly for 28 days. The second group was divided into 2
subgroups (18 rats/subgroup), animals of these sub-
groups treated for 28 consecutive days as follows:
Subgroup I (BDL) Rats of this subgroup administered
distilled water orally.
Subgroup II (HaE) Animals of this subgroup treated or-
ally with HaE (200 mg/kg body weight).
Animals handling
Animals were euthanized on the 8th, 15th and 29thdays
of treatment after being fasted overnight under deep
anesthesia with ketamine and chlorpromazine. Blood
collected by cardiac puncture. Blood was collected in
centrifuge tubes. Liver was removed and immediately
blotted using filter paper to remove traces of blood and
then divided into two parts, the first part stored at −80°C
for biochemical analysis. While, the second part was
suspended in 10% formal saline for fixation and prepar-
ation to histological processing.
Sample preparation
Serum preparation
Blood samples collected in centrifuge tubes were centri-
fuged at 3000 rpm for 20 minutes. Serum stored at −20°C
until used for biochemical assays.
Liver homogenate preparation
Liver tissue was homogenized (10% w/v) in ice-cold
0.1 M Tris–HCl buffer (pH 7.4). The homogenate was
centrifuged at 3000 rpm for 15 min. at 4°C and the
resultant supernatant used for biochemical analysis.
Histopathological study
Liver slices were fixed in 10% formal saline and embed-
ded in paraffin wax blocks. Sections of 5 μm thick were
stained with hematoxylin & eosin (H&E) then examined
under light microscope for determination of pathological
changes [28]. Picrosirius Red stains of paraffin-embedded
sections were used to qualitatively assess collagen
architecture and extent of fibrosis. Morphometric ana-
lysis for fibrosis quantification was performed using 10
photographs of random high-power fields (200×) for
each liver sample. These images were analyzed with
LIVARQ500 software (Pathology department of National
Research Center).
Biochemical analysis
Serum biomarkers for liver function tests and total protein
level
The appropriate kits (Bio-Diagnostic, Dokki, Giza, Egypt)
was used for the determination of total protein by colori-
metric method according to the method described by
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end point method according to modified bromocresol
green binding assay (BCG), Tietz [30]. Serum aminotrans-
ferase enzyme activities (ASAT & ALAT) were determined
according to Reitman and Frankel [31]. All assays were
made according to the instructions of the manufacturer.
Serum cholestatic indices
Alkaline phosphatase was assayed by the appropriate kits
(Bio-Diagnostic, Dokki, Giza, Egypt) according to the
method of Belfield [32]. Total bilirubin and direct biliru-
bin were measured by the method of Walter and Gerade
[33]. Indirect bilirubin was calculated as follows:
Indirect bilirubin ¼ Total bilirubin−direct bilirubin
Oxidative stress markers assessment
Oxidative stress markers were detected in the resultant
supernatant of liver homogenate. The appropriate kits
(Biodiagnostic kits, Biodiagnostic Dokki, Giza, Egypt) were
used for the determination of malondialdehyde (MDA)
[34], glutathione reduced (GSH) [35], catalase (CAT) [36],
glutathione-S-transferase (GST) [37] and superoxide dis-
mutase (SOD) [38]. All assays were made according to the
instructions of the manufacturer.
Statistical analysis
Values were expressed as means ± SE. To evaluate differ-
ences between the groups studied, one way analysis of
variance (ANOVA) with the Duncan post hoc test was
used to compare the group means and P < 0.05 was con-
sidered statistically significant. SPSS for Windows (version
15.0) was used for the statistical analysis.
% improvement = treated mean - injured mean/control
mean × 100.Figure 1 Antioxidant activity of Holothuria arenicola extract (HaE) and
change of 6 mice. *: significant at p < 0.05 as compared to the ascorbic aciResults
Acute toxicity
From the experiment performed as per the OECD
Guidelines 420, the results reveal that the Holothuria
arenicola (HaE), has been found toxic at 5000 mg/kg
body weight of experimental animals as in the first
4 hours of observation2/3 morbidity was observed. None
of the 6 rats died or showed any sign of toxicity at the
limit dose of 2000 mg/kg p.o. for HaE in the first 48 h.
No evidence of toxicity was noticed during the period of
observation. The LD50 was therefore taken as above
2000 mg/kg p.o. The median effective dose (ED50) was
selected based on the proposed LD50 obtained from the
acute toxicity study. This dose was considered one tenth
of the proposed LD50, that is, 200 mg/kg body weight.Free radical scavenging activity
The results of DPPH scavenging activity of HaE and ascor-
bic acid were shown in the Figure 1. The radical scavenging
activities were estimated by comparing the percentage of
inhibition of DPPH radical to the tested extract and the
ascorbic acid. The data were displayed with mean ± SEM of
three replications. The present results showed that HaE
produced dose dependent inhibition of DPPH radical ran-
ging from (82.3 to 95.2%) as compared to ascorbic acid.Phenolic compounds in the Holothuria arenicola extract
High-performance liquid chromatography analysis of
HaE revealed the presence of seven non-volatile phenolic
compounds, two of which were unidentified under the
adopted conditions. Chlorogenic acid was the major com-
ponent (89.66%), whereas ascorbic acid (0.077%) was the
minor component. Other components, such as pyrogallol
(1.88%), rutin (1.06%) and coumaric acid (1.23%) were
recorded in Figure 2.ascorbic acid. Each vertical column represents the mean ± SEM of
d.
Figure 2 High-performance liquid chromatographic analysis of Holothuria arenicola extract.
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Representative views of liver sections are shown in Figure 3.
As shown in tissue sections stained with hematoxylin
and eosin, compared with liver sections of the Sham
group, BDL caused prominent proliferation of Kupffer
cells (K), abundant adipocytes (A) and marked depos-
ition of collagen fibers (arrow). For a long time period
(28 days), liver sections showed necrosis, apoptosis
and abundant marked deposition of collagen fibers
leading to loss of hepatic lobular architecture. Oral ad-
ministration of HaE daily for 14 and 28 days improved the
hepatic architecture; as compared to the corresponding
BDL group and it apparently suppressed hepatic fibro-
genesis by reducing the thickness of bridging fibrotic
septa.
To assess the impact of HaE on hepatic fibrogenesis
caused by BDL, liver sections were stained with picro-
Sirius red for detecting the deposition of collagens.
Compared with sections from the Sham control groups
(Figure 4 A 1, 2 &3), liver sections from BDL rats showed
prominent red staining in the fibrotic septa between
nodules (Figure 4 B 1, 2 &3) suggesting a high level of colla-
gen deposition. HaE treatment remarkably reduced the
size stained with Sirius red in the liver (Figure 4 C 1, 2 &3).
BDL for 14 and 28 days recorded highest collagen percent-
ages deposition 38.46 and 44.19%, respectively (Figure 5).
Treatment with HaE for 28 days recorded a significant
decrease (p < 0.05) in the collagen deposition percent-
age recording 19.91% (Figure 5).
Efficiency of Holothuria arenicola extract on liver function
enzymes, serum protein and serum albumin content
BDL group showed a significant increase (p < 0.05) in
ASAT, ALAT and total protein levels following the three
tested periods as compared to the corresponding Sham
group (Table 1). While, serum albumin content de-
creased significantly (p < 0.05) after all tested periods.However, treatment with HaE significantly decreased
(p < 0.05) serum ASAT and ALAT activities, but signifi-
cantly increased serum albumin content after the three
tested periods. The observed changes in the liver func-
tion enzymes after 28 days of treatment recorded the
most improvement percentages than the other two
tested periods. ASAT and ALAT levels were ameliorated
by 77.86 and 70.15%, respectively, while the serum albu-
min content was ameliorated by 60.16%.
Efficiency of Holothuria arenicola extract on serum
cholestatic markers
As shown in Table 2, serum alkaline phosphatase activity,
total bilirubin, direct bilirubin and indirect bilirubin levels
were significantly higher in BDL rats as compared to their
corresponding controls (P < 0.05). Administration of HaE
to BDL group reduced ALP activity significantly (P < 0.05)
after the three tested periods. Meanwhile, total bilirubin,
direct bilirubin and indirect bilirubin decreased signifi-
cantly (P < 0.05) following treatment with HaE for 7, 14
and 28 days. All studied cholestatic markers recorded
highest improvement percentages following 28 days of
HaE treatment.
The potency of Holothuria arenicola extract in improving
the oxidative status of the liver
Malondialdehyde (MDA) and reduced glutathione (GSH)
levels as well as glutathione-S-transferase (GST), catalase
(CAT) and super oxide dismutase (SOD) activities in
control, BDL and HaE administered rats were shown in
Table 3.
MDA levels were assessed as an indicator of lipid peroxi-
dation. The liver MDA was found to be higher in the BDL
group compared to their corresponding Sham-operated
control groups following all tested periods, but this in-
crease was significant (P < 0.05) only after 28 days of bile
duct ligation. Treatment with HaE significantly decreased
Figure 3 Histological study of hematoxylin& eosin stained liver sections (400×) of Sham, BDL and Holothuria arenicola extract (HaE)
treated rats. Sham treated liver showing normal hepatocytes (H) and separated by blood sinusoids (S). Bile duct ligated liver showing liver fibrosis
indicated by adipocytes (A) and many collagen fibers (arrows). HaE- treated liver sections demonstrating the regeneration of liver parenchyma and
light fibrosis.
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ment (Table 3). However, the maximum improvement per-
centage was recorded following 28 days of HaE treatment.
The hepatic GSH level showed a marked reduction
in the BDL group (P < 0.05) compared to their corre-
sponding Sham-operated control group. However, this
reduction was significantly (P < 0.05) following 14 and
28 days after bile duct ligation. Administration of HaE
for 14 and 28 days significantly (P < 0.05) increased the
level of GSH as compared to their corresponding BDL
group (Table 3). The highest improvement percentage
was recorded following 14 days of HaE treatment.
Bile duct ligation significantly (P < 0.05) decreased the
level of CAT in the liver tissues in all tested groups, as
compared to their corresponding controls (Table 3).
However, treatment with HaE at 7, 14 and 28 days
significantly (P < 0.05) increased the levels of CAT, as
compared to the time matched BDL groups.
As shown in Table 3, bile duct ligation significantly
decreased (P < 0.05) GST activity, as compared totheir time matched sham groups following all tested
time periods. Treatment with HaE for 7, 14 and
28 days caused significant increase (P < 0.05) in the
GST activities as compared with their corresponding
BDL groups.
Concerning the effect of bile duct ligation on the SOD
activity, bile duct ligation significantly (P < 0.05) de-
creased the level of SOD in the liver tissues in all the
tested groups, as compared to their corresponding con-
trols (Table 3). However, treatment with HaE at all
tested periods significantly (P < 0.05) increased the levels
of SOD as compared to their time matched BDL groups.
The highest improvement percentage was recorded fol-
lowing 14 days of HaE treatment.
Discussion
Chronic liver disease is an important cause of morbidity
and mortality and represents a major health problem
worldwide [39]. The high prevalence of chronic liver dis-
eases in Egypt has led to increasing numbers of Egyptian
Figure 4 Histological study of picrosirius red -stained liver sections
(200×) of Sham, BDL and Holothuria arenicola extract (HaE)
treated rats. Rats were grouped: group 1, rats treated for 7 days; group
2, rats treated for 14 days and group 3, rats treated for 28 days. Liver
sections from: (A) Control (Sham operated) rats; (B) bile duct-ligated rats;
(C) bile duct-ligated rats and treated with Holothuria arenicola extract
(HaE). Arrows indicated collagen deposition stained by picrosirius red.
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For the therapeutic strategies of liver injury and disease,
it is important to find an antioxidant compound that is
able to block liver injuries through the free radicals gen-
erated through toxic chemicals. During the course of
evolution, many invertebrates have established as a
selective advantage by endogenous production of pro-
tective chemicals [42]. The sea cucumber (Holothuria)
is a marine invertebrate of the phylum Echinoderm and
the class Holothuroidea found on the sea floor world-
wide [43]. Recently, Esmat et al. [21] studied the anti-
oxidant potential, and hepatoprotective activity of sea
cucumber (Holothuria atra) against thioacetamideFigure 5 Percentages of collagen deposition in Sham, BDL and Holoth
Unshared letters between groups are the significance values at p < 0.05.intoxication in rats. So, the present study aimed to in-
vestigate the therapeutic effect of phosphate buffer ex-
tract of the sea cucumber Holothuria arenicola in bile
duct ligated rats.
Bile duct ligation model in rats has been used to study
the mechanisms of new natural products in human
patients with liver cirrhosis [44,45]. Phenolic-rich mate-
rials such as phytoplankton and particles derived from
degrading marine macro-algae are the main sources of
food for sea cucumbers, that can account for the pres-
ence of the active phenolic compounds in the body wall
of sea cucumbers [43]. Phenolic compounds are very
important because of their antioxidant activity [46]. The
antioxidant activity of phenolic compounds is mainly
attributable to their redox properties that play an im-
portant role as free radical scavengers, reducing agents,
quenchers of singlet oxygen and complexes of pro-
oxidant metals [47]. High-performance liquid chroma-
tography analysis of the phenolic compounds in the
HaE revealed the presence of 89.66% of chlorogenic
acid. Chlorogenic acid is one of the most abundant
polyphenols in the human diet and its potential hepato-
protective effect in several animal models of liver injury
was reported [48].
Bile duct ligation induces a kind of liver fibrosis, that
etiologically and pathogenitically resembles the biliary
fibrosis in the human beings and is shown to induce
cholestasis-related liver function impairments [49]. The
most remarkable pathological characteristics of BDL
-induced hepatotoxicity is increased production and de-
position of extracellular matrix (ECM) component that
accompanies most chronic liver disorders and its pres-
ence is a major factor contributing to hepatic failure
[50]. The continuous accumulation of the ECM causes
hepatofibrosis. Histopathological finding in the presenturia arenicola extract (HaE) treated rats for 7, 14 and 28 days.
Table 1 Effect of Holothuria arenicola extract on liver function enzymes and total protein level in serum of BDL rats
Parameters Time period Groups % of improvement
Sham BDL HaE
ASAT (IU/L) 7 149.70 ± 9.57b 191.55 ± 5.87c 147.25 ± 7.82b 29.59
14 143.14 ± 9.08b 208.25 ± 10.02c 145.35 ± 10.4b 43.94
28 144.90 ± 8.63b 262.85 ± 7.93d 150.02 ± 5.64b 77.86
ALAT (IU/L) 7 55.51 ± 0.99a 77.31 ± 5.39b 71.65 ± 4.27b 10.20
14 54.18 ± 1.2a 103.86 ± 2.62c 67.95 ± 2.75b 66.27
28 55.52 ± 1.1a 110.35 ± 5.25c 71.05 ± 5.45b 70.15
Serum total protein (mg/100 ml) 7 4.11 ± 0.46a 12.62 ± 0.5c 10.5 ± 1.47b 51.58
14 4.15 ± 0.5a 14.86 ± 2.91b 12.95 ± 1.54bc 41.68
28 4.17 ± 0.51a 15.42 ± 1.89bc 13.43 ± 0.84bc 47.72
Serum albumin content (g/100 ml) 7 5.51 ± 0.32c 2.81 ± 0.15a 3.51 ± 0.52ab 14.42
14 5.86 ± 0.33c 3.84 ± 0.39ab 4.50 ± 0.22b 11.43
28 6.1 ± 0.22c 2.63 ± 0.47a 6.30 ± 0.08c 60.16
Data are means ± SEM of six rats in each group.
Unshared letters between groups are the significance values at p < 0.05.
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that fibrosis leads to loss of normal architecture of the
liver. The present study extended to confirm the finding
of Friedman [52], who reported that collagen is the main
component of the extracellular matrix in the fibrotic tis-
sue. Preclinical studies have identified many potential
therapies for fibrosis. These include interruption of
matrix deposition and hence inhibition of collagen syn-
thesis [53]. The extent of collagen contents assessed by
the many fibrous septa within each microscopic field of
liver tissues. The present study demonstrated an appar-
ent arrest in the progression of collagen deposition in
the HaE treated animals that can be a consequence of
the increased mass of regenerated liver cells. This gives anTable 2 Effect of Holothuria arenicola extract on serum choles
Parameters Time period Groups
Sham
ALP (IU/L) 7 149.49 ± 12.63a
14 148.55 ± 12.88a
28 149.75 ± 12.69a
Total bilirubin (mg/100 ml) 7 0.50 ± 0.08a
14 0.48 ± 0.08a
28 0.47 ± 0.08a
Direct bilirubin (mg/100 ml) 7 0.19 ± 0.02a
14 0.20 ± 0.02a
28 0.25 ± 0.02a
Indirect bilirubin (mg/100 ml) 7 0.24 ± 0.02a
14 0.24 ± 0.02a
28 0.28 ± 0.2a
Data are means ± SEM of six rats in each group.
Unshared letters between groups are the significance values at p < 0.05.additional support that HaE is able to condition the hepa-
tocytes, accelerates regeneration of parenchyma cells,
protects against membrane fragility and hence decreases
leakage of the enzymes into circulation.
In BDL model, the hepatocellular excretion of bile
constituents is markedly impaired eliciting its retention
within hepatocytes. Cholestasis syndrome includes liver
function disorder attributable to the obstruction of bile
drainage into the intestine, with the consequent reten-
tion of bile constituents in the liver and their regurgita-
tion in the blood [54,55]. In the condition of cholestasis,
primarily hydrophobic bile salts and bilirubin have the
most significant toxic effects [56]. In conjunction with
the report of Zajic et al. [56] and Kim et al. [57], datatatic markers of BDL rats
% of improvement
BDL HaE
218.29 ± 4.00b 208.51 ± 19.31b 6.5
250.80 ± 26.41b 247.14 ± 4.84b 2.46
247.18 ± 3.30b 153.70 ± 14.27a 62.40
1.42 ± 0.67b 0.44 ± 0.8a 196
1.30 ± 0.38b 0.43 ± 1.72 a 181
1.41 ± 0.72b 0.53 ± 0.42a 206
1.18 ± 0.4b 1.02 ± 0.38a 84.21
1.45 ± 0.31b 1.10 ± 0.54a 175
1.99 ± 0.17b 1.42 ± 0.30a 228
1.3 ± 0.31b 1.09 ± 0.24a 87.5
1.01 ± 0.46b 0.62 ± 0.76c 162.5
1.61 ± 0.56b 0.98 ± 0.76c 225
Table 3 Effect of Holothuria arenicola extract on the liver oxidative statues of BDL rats
Parameters Time period Groups % of improvement
Sham BDL HaE
MDA (nmol/gm tissue) 7 8.15 ± 0.57bc 8.79 ± 0.14c 8.10 ± 0.13bc 8.47
14 8.13 ± 0.59 bc 9.32 ± 0.37c 7.38 ± 0.46ab 23.86
28 8.13 ± 0.57bc 15.04 ± 0.42d 6.77 ± 0.60a 101.72
GSH (mg/gm tissue) 7 7.79 ± 0.91b 6.65 ± 0.21ab 7.7 ± 0.68b 13.47
14 7.84 ± 0.87b 5.28 ± 0.22a 8.41 ± 0.62b 39.79
28 7.84 ± 0.89b 4.77 ± 0.62a 7.64 ± 0.39b 36.61
CAT (U/min) 7 2.10 ± 0.19c 0.60 ± 0.03b 2.75 ± 0.31ac 102
14 2.09 ± 0.26c 0.56 ± 0.03b 2.47 ± 0.52ac 92
28 2.08 ± 0.17c 0.16 ± 0.08b 1.66 ± 0.28ab 72
GST (nmol/min/gm tissue) 7 0.05 ± 0.003c 0.03 ± 0.002b 0.04 ± 0.003ac 20
14 0.04 ± 0.008cd 0.03 ± 0.002b 0.04 ± 0.005ac 25
28 0.05 ± 0.004c 0.02 ± 0.006a 0.05 ± 0.002bc 60
SOD (U/gm tissue) 7 64.68 ± 2.18d 52.61 ± 4.83bc 54.87 ± 4.14bcd 3.94
14 67.22 ± 1.94d 39.66 ± 2.56a 47.401 ± 3.23ab 11.52
28 60.43 ± 1.28cd 38.54 ± 3.15a 60.81 ± 1.33cde 36.85
Data are means ± SEM of six rats in each group.
Unshared letters between groups are the significance values at p < 0.05.
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portant and reliable biochemical indicators of bile flow
interruption were the increased values of bilirubin. In
the present study, the maximum increase in conjugated
(direct) bilirubin was recorded following 7 days. This
result confirmed the finding of Zajic et al. [56], who
reported that, the predominant hyper bilirubinaemia is
always conjugated at the beginning of cholestasis when
the damages are smaller. As the cholestasis dominates, a
part of the direct bilirubin moves into blood plasma
leads to hyperbilirubinemia of conjugated type [55]. The
increased value of direct bilirubin in plasma following
BDL may be due to a consequence of the increased
concentration gradient between the cells and plasma or
flowing out of bilirubin attributable to cell damages
caused by obstruction in the bile flow [56,55].
Histological alterations and an increase in alkaline
phosphatase (ALP) levels confirmed the damage pro-
duced by the bile duct ligation in rats [58]. In conson-
ance with the findings of Nasehi et al. [49] and Kim
et al. [57], the data recorded in the present study showed
significant enhancement of the ALP activity following
BDL in rats. This increase may be attributable to the re-
tention of bile salts that damaged the membrane and
consequently leads to the passing of the ALP enzyme
into circulation [59,60]. It is known that, liver and bile
duct disorders are followed by increased activity of ALP
which is especially characteristic of the cholestastic syn-
drome [56]. Moreover, it has already been proved that in
cholestasis the bile salts induce synthesis of new mole-
cules of ALP [61]. The present study showed thattreatment with HaE for 7 and 14 days failed to
normalize the ALP level. Viewed in conjunction with the
finding of Zajic et al. [56], alkaline phosphatase takes
much longer to return to normal values and sometimes
remains permanently increased despite the clinically suc-
cessful biliary reconstruction. On the other hand, a de-
crease in collagen deposition and a reduction in ALP
levels in the HaE group after 28 days of treatment sug-
gest a better outcome in the treated groups.
In the assessment of liver damage, the determination
of enzyme levels, such as serum aminotranferases, ASAT
and ALAT usually used for the accurate detection and
early diagnosis. The present study confirmed the finding
of Olteanu et al. [62], who explained elevation in the
serum enzymes ASAT and ALAT to the increase in hep-
atic cell membrane fluidity that led to enzyme release
into circulation. In accord with the finding of Esmat
et al. [21], the administration of HaE substantially atten-
uated the flares of the hepatic enzymes as evident by
77.86, 70.15 and 47.72% improvement in the activities of
serum ASAT, ALAT and ALP respectively, in the BDL
treated rats indicating maintenance of functional integ-
rity of hepatic cell membrane.
Albumins as negative inflammatory reactants and
markers of impaired synthetic liver function were signifi-
cantly lower in patients with extrahepatic cholestasis [55].
In accord with the studies of Zajic et al. [56], the present
study showed significant decrease in the albumin contents
following the three tested periods after BDL in rats. It was
reported that hypoalbuminaemia is most frequent in the
presence of advanced chronic liver diseases [42]. The
Fahmy BMC Complementary and Alternative Medicine  (2015) 15:14 Page 10 of 12reduction in the albumin content in the present investi-
gation may be attributable to significant damage of
synthetic function of the liver resulting in decreased
capability of the liver to synthesize albumins, that is
manifested by the inverse correlation between the
values of albumins and the increase of direct bilirubin.
However, treatment of BDL- rats with HaE for 28 days
bring back the level of albumin near to normal levels.
Stimulation of albumin synthesis has been advanced as a
contributory hepatoprotective mechanism, that accelerates
the regeneration process and the production of liver cells
[63]. Enhancement of the total protein content can be
deemed as a useful index of the severity of cellular dys-
function in liver diseases as clearly shown in our studies.
In consonance with the finding of Sharma and Shukla
[64], the present study showed a significant increase in the
total protein following BDL that may be a contributory
self-healing mechanism that accelerates liver regeneration
process. It was reported that liver dramatically increases
the synthesis of certain proteins during the acute-phase
response to the stress of the BDL [65]. Furthermore,
systemic endotoxemia that frequently follows BDL could
lead to increased neutrophilic response and increasing
circulating visceral proteins [66].
Oxidative stress in cholestatic liver disease is a sys-
temic phenomenon [67]. It was reported that oxidative
stress occurs during cholestasis plays a role in choles-
tasis induced liver injury [68,39]. In accord with the
reports of Kim et al. [57], the intensity of oxidative
stress measured as an increase in the levels of lipid per-
oxidation end product, malondialdehyde (MDA) in the
liver of BDL rats following all experimental periods.
The elevation in MDA suggests enhanced lipid peroxi-
dation leading to tissue damage and failure of antio-
xidant defense mechanisms to prevent formation of
excessive free radicals. The underlying mechanisms of
increased systemic oxidative stress during cholestasis
may be attributable to the retention of toxic bile acids,
that stimulate the generation of reactive oxygen species
(ROS) in hepatocytes which stimulate lipid peroxida-
tion [10]. Moreover, Schmucker et al. [69] have shown
that the hydrophobic bile acids damaged the hepato-
celular membrane attributable to their detergent-like
influence which confirmed in the present investigation
by the histopathological examination. In conjunction
with the reports of Damnjanović et al. [55], the present
study showed positive correlation between oxidative
stress and hyper bilirubinaemia noticed in the present
study, which may be considered as a form of protective
effect [55]. However, the decrease of lipid peroxidation-
mediated oxidative stress may be a potential and effect-
ive strategy for the prevention and treatment of hepatic
failure [70]. The present study affirmed the finding of
Esmat et al. [21], who reported that sea cucumber bodywall extract significantly decreased MDA levels in
injured liver tissues, suggesting that the antifibrotic
mechanism of HaE may be attributable to its phenolic
antioxidant effect.
Glutathione reduced (GSH), a key antioxidant, is an
important constituent of intracellular protective mecha-
nisms against various noxious stimuli including oxidative
stress [71]. Because of their exposed sulfhydryl groups,
non-protein sulfhydryls bind a variety of electrophilic
radicals and metabolites that may be damaging to the
cells [72]. Reduced amount of glutathione in patients
with cholestasis decrease hepatobiliary transport of toxic
organic components leading to the development of com-
plications accompanying cholestasis [73]. Insufficiency in
non-enzymatic antioxidant GSH following BDL could be
the consequence of increased utilization for trapping
free radicals. In accordance with the report of Þener
et al. [71] and Kim et al. [57], our results also support
the notion that depletion of tissue GSH as observed in
the BDL-induced hepatic injury is one of the major
factors that permit lipid peroxidation and subsequent
tissue damage. Treatment with HaE in the present study
restored GSH content following the three tested periods.
In accord with our results, Gaté et al. [74] and Fahmy &
Hamdi [42] have reported that dietary supplementation
of the marine extract of the Crassostrea gigas clams and
mantis shrimp Erugosquilla massavensis increased GSH
level in the liver of rats. This increase is a reflection of
increased synthesis of GSH in the liver [75].
Viewed in conjunction with the finding of Somi et al.
[76], the present study demonstrated that bile duct ligation
usually decreases antioxidant enzyme (GST, SOD and
CAT) activities in hepatic tissue that may be attributable
to mitochondrial toxicity induced by intrahepatocyte con-
centration of biliary acids in chronic cholestasis. In accord
with our results, Sanzgiri et al. [77] have reported that the
enhanced free radical concentration resulting from the
oxidative stress conditions can cause loss of enzymatic
activity. Moreover, the enhancements in antioxidant
enzyme activities may prevent the accumulation of
excessive free radicals and protect liver following BDL.
Tissues and cells would be subjected to oxidative injuries
when large quantities of inner free radicals are generated
or the activities of antioxidant system deteriorate. Accord-
ingly, antioxidant therapy represents a potential strategy
to prevent liver injury and fibrosis. Treatment with HaE
normalized the antioxidant levels through their rich of
polyphenolic compound especially chlorogenic acid that
has the ability to scavenge free radicals.
Conclusion
The present prospective study serves to extend the grow-
ing number of our earlier investigations on therapeutic
products from aquatic sources and confirm that HaE
Fahmy BMC Complementary and Alternative Medicine  (2015) 15:14 Page 11 of 12improved antioxidant status, and thereby prevented liver
damage following cholestasis. The antifibrotic effect of
HaE produced maximum improvement following 28 days
of treatment that may be attributable to its phenolic com-
pounds specially chlorogenic acid.
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